NANOPROTEC
Live / Registered — Registered (as of 19 Aug 2025)
What this means for you
Registered since 19 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98338086
- Registration number
- 7896232
- Mark type
- Stylized text
- Filed
- 02 Jan 2024
- Published for opposition
- 03 Jun 2025
- Registered
- 19 Aug 2025
- Attorney of record
- Pina Campagna
Goods and services
- Class 005 — Pharmaceuticals: Monoclonal antibodies for medical purposes, namely, monoclonal antibodies for the treatment or prevention of intestinal bacteria in animals; Reagents for medical use, namely, immunological reagents for the treatment or prevention of intestinal bacteria in animals; reagents for medical use; pharmaceutical preparations for veterinary purposes, namely, pharmaceutical preparations for the treatment or prevention of intestinal bacteria; veterinary preparations for livestock animals for the treatment or prevention of intestinal bacteria; chemical preparations for veterinary purposes, namely, chemical preparations for the treatment or prevention of intestinal bacteria; biological preparations for veterinary purposes, namely, biological preparations for the treatment or prevention of intestinal bacteria
Owner
Prosecution history
- 19 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Jun 2025 — PUBLISHED FOR OPPOSITION
- 28 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Apr 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 10 Mar 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 10 Mar 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 10 Dec 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 10 Dec 2024 — FINAL REFUSAL E-MAILED
- 10 Dec 2024 — FINAL REFUSAL WRITTEN
- 05 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED